203 related articles for article (PubMed ID: 26896384)
1. Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience.
Edwards BJ; Sun M; West DP; Guindani M; Lin YH; Lu H; Hu M; Barcenas C; Bird J; Feng C; Saraykar S; Tripathy D; Hortobagyi GN; Gagel R; Murphy WA
J Bone Miner Res; 2016 Aug; 31(8):1569-76. PubMed ID: 26896384
[TBL] [Abstract][Full Text] [Related]
2. Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
Koh JH; Myong JP; Jung SM; Lee J; Kwok SK; Park SH; Ju JH
Arthritis Rheumatol; 2016 Jan; 68(1):77-82. PubMed ID: 26360133
[TBL] [Abstract][Full Text] [Related]
3. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
[TBL] [Abstract][Full Text] [Related]
4. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster DW; Ebeling PR; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Howe TS; van der Meulen MC; Weinstein RS; Whyte MP
J Bone Miner Res; 2014 Jan; 29(1):1-23. PubMed ID: 23712442
[TBL] [Abstract][Full Text] [Related]
5. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD
J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data.
Mahjoub Z; Jean S; Leclerc JT; Brown JP; Boulet D; Pelet S; Grondin C; Dumont J; Belzile ÉL; Michou L
J Bone Miner Res; 2016 Apr; 31(4):767-76. PubMed ID: 26588590
[TBL] [Abstract][Full Text] [Related]
7. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy.
Yang SP; Kim TW; Boland PJ; Farooki A
Oncologist; 2017 Apr; 22(4):438-444. PubMed ID: 28275116
[TBL] [Abstract][Full Text] [Related]
9. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.
Lo JC; Neugebauer RS; Ettinger B; Chandra M; Hui RL; Ott SM; Grimsrud CD; Izano MA
BMC Musculoskelet Disord; 2020 Dec; 21(1):801. PubMed ID: 33272248
[TBL] [Abstract][Full Text] [Related]
10. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
Black DM; Abrahamsen B; Bouxsein ML; Einhorn T; Napoli N
Endocr Rev; 2019 Apr; 40(2):333-368. PubMed ID: 30169557
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting.
LeBlanc ES; Rosales AG; Black DM; Genant HK; Dell RM; Friess DM; Boardman DL; Bauer DC; de Papp A; Santora AC; Orwoll ES
J Bone Miner Res; 2017 Nov; 32(11):2304-2314. PubMed ID: 28731209
[TBL] [Abstract][Full Text] [Related]
12. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
Lee SH; Lee YH; Suh JS
AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate therapy associated with bilateral atypical femoral fracture and delayed union.
Gárgyán I; Dózsai D; Csonka I; Rárosi F; Bodzay T; Csonka Á
Jt Dis Relat Surg; 2022; 33(1):24-32. PubMed ID: 35361077
[TBL] [Abstract][Full Text] [Related]
14. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.
Lo JC; Hui RL; Grimsrud CD; Chandra M; Neugebauer RS; Gonzalez JR; Budayr A; Lau G; Ettinger B
Bone; 2016 Apr; 85():142-7. PubMed ID: 26769007
[TBL] [Abstract][Full Text] [Related]
15. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.
Lo JC; Grimsrud CD; Ott SM; Chandra M; Hui RL; Ettinger B
Osteoporos Int; 2019 Dec; 30(12):2515-2520. PubMed ID: 31555883
[TBL] [Abstract][Full Text] [Related]
16. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture.
Farlay D; Rizzo S; Ste-Marie LG; Michou L; Morin SN; Qiu S; Chavassieux P; Chapurlat RD; Rao SD; Brown JP; Boivin G
J Bone Miner Res; 2021 Jun; 36(6):1031-1041. PubMed ID: 33434290
[TBL] [Abstract][Full Text] [Related]
17. Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.
Lee YK; Ahn S; Kim KM; Suh CS; Koo KH
J Korean Med Sci; 2018 Jan; 33(5):e38. PubMed ID: 29349947
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy-A Registry-Based Cohort Study.
Everts-Graber J; Bonel H; Lehmann D; Gahl B; Häuselmann H; Studer U; Ziswiler HR; Reichenbach S; Lehmann T
JBMR Plus; 2022 Oct; 6(10):e10681. PubMed ID: 36248270
[TBL] [Abstract][Full Text] [Related]
19. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.
Takahashi M; Ozaki Y; Kizawa R; Masuda J; Sakamaki K; Kinowaki K; Umezu T; Kondoh C; Tanabe Y; Tamura N; Miura Y; Shigekawa T; Kawabata H; Baba N; Iguchi H; Takano T
BMC Cancer; 2019 Oct; 19(1):980. PubMed ID: 31640606
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical center.
Bareli N; Gat R; Makarov V; Siris E; Fraenkel M; Yoel U
Arch Osteoporos; 2021 Jun; 16(1):86. PubMed ID: 34089098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
